Atlas Trials

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

Clinical trial NCT01766401 · COMPLETED

Trial details

NCT number
NCT01766401
Sponsor
Forest Laboratories
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Generalized Anxiety Disorder
Start date
2013-01-31
Primary completion
2014-01-29
Enrollment
402

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.